 |
|
|
| |
Safety and Drug-Drug Interaction of Tropifexor in Combination With Licogliflozin in Healthy but Overweight
to Obese Subjects in Support of a Ph2b Combination Study ELIVATE
|
| |
| |
AASLD 2020 Nov 11-16
Reported by Jules Levin
Jessie Gu1, Markus Weiss2, Wendy Weis3, Bharti Shah3, William Prince1, Jin Chen3, Ralph Woessner2, Chinweike Ukomadu1, Felicity Schaefer3, and Patricia Lopez4
1Novartis Institutes for Biomedical Research, Cambridge, USA; 2Novartis Institutes for Biomedical Research, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, USA; 4Novartis Pharma AG, Basel, Switzerland
|
| |
|
|
|
|
|
